Correlation between Total Lymphocyte Count, Hemoglobin, Hematocrit and CD4 Count in HIV/AIDS Patients
,
Abstract
Lymphocyte CD4+count, a standard laboratory test for staging of HIV infection, is expensive and unavailable in resource-restricted countries. Total lymphocyte count (TLC) and hemoglobin (Hb) are recommended as simple & inexpensive surrogates. The aim of this study was to assess the correlation, sensitivity and predictive power of these parameters as substitutes for CD4 count. One hundred HIV patients enrolled in this analytic descriptive study in Ahvaz, a city in the South of Iran, from 2005 to 2006. They were tested for CD4 count, TLC, Hb, and hematocrit (Hct). The cutoffs were determined as: 200 cells/µL, 1200 cells/µL, 12 g/dl and 30%, respectively. We used Sys Max SE 9500 for CBC and Flow cytometry for CD4 count. The correlation coefficient established correlation between values. Sensitivity, specificity and positive predictive values were calculated. 2 females (%2) and 98 males (%98) of the mean age of 32±5 years were studied. 87 cases (%87) were IV drug users, the majority having a history of imprisonment. The mean CD4 count, TLC, Hb and Hct were 279±225, 2102±1250, 10.7±2.4 and 30.4±9.0, respectively. A strong correlation was observed between CD4 count and TLC (R = 0.645, P = 0.001), but no correlation was seen between CD4 count and Hb or Hct (R= 0.451, P=0.056 and R= 0.375, P=0.816 respectively). This study shows that TLC is a suitable surrogate marker for CD4 count. Hb and Hct are of limited value in predicting CD4 counts and should not be substituted for CD4counts.
World Health Organization. Scaling up antiretroviral therapy= in resource-limited Settings: treatment guidelines for a public health approach. 2003 revision. Geneva, World Health Organization, 2003.
Kumarasamy N, Flanigan TP, Mahajan AP, Carpenter CC, Mayer KH, Solomon S, et al. Monitoring HIV treatment in the developing world. Lancet Infect Dis 2002; 2(11): 656-7.
World Health Organization. World Health Report on HIV/AIDS 2000, 2000.
Akinola NO, Olasode O, Adediran IA, Onayemi O, Murainah A, Irinoye O, et al. The search for a predictor of CD4 cell count continues: total lymphocyte count is not a substitute for CD4 cell count in the management of HIV-infected individuals in a resource-limited setting. Clin Infect Dis 2004; 39(4): 579-81.
Spacek LA, Griswold M, Quinn TC, Moore RD. Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource- limited settings. AIDS 2003; 17(9): 1311-7.
Badri M, Wood R. Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resourcelimited settings. AIDS 2003; 17(4): 541-5.
Lee SS, Wong KH. The use of total lymphocyte count (TLC) as an independent criterion for initiating HAART inresource-poor countries. J Infect 2005; 50(1): 66-7.
Center of Control of Diseases, Ministry of Health of Iran, report of HIV/AIDS, 2004.
Kumarasamy N, Mahajan AP, Flanigan TP, Hemalatha R,Mayer KH, Carpenter CC, et al. Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr 2002; 31(4): 378-83.
Post FA, Wood R, Maartens G. CD4 and total lymphocyte counts as predictors of HIV disease progression. QJM 1996; 89(7): 505-8.
van der Ryst E, Kotze M, Joubert G, Steyn M, Pieters H, van der Westhuizen M, et al. Correlation among total lymphocytecount, absolute CD4+ count, and CD4+ percentage in a group of HIV-1-infected South African patients. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19(3): 238-44.
Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, Margolick JB. Rapid declines in total lymphocyte counts and hemoglobin concentration prior to AIDS among HIV-1- infected men. AIDS 2003; 17: 2035-44.
| Files | ||
| Issue | Vol 47, No 1 (2009) | |
| Section | Articles | |
| Keywords | ||
| TL-CD4count total lymphocyte count hemoglobin hematocrite HIV/AIDS | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
